{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:21:40Z","timestamp":1790774500954,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.euroneuro.2014.08.018","type":"journal-article","created":{"date-parts":[[2015,3,4]],"date-time":"2015-03-04T23:53:37Z","timestamp":1425513217000},"page":"1060-1081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Quantifying motivational deficits and apathy: A review of the literature"],"prefix":"10.1016","volume":"25","author":[{"given":"Mark","family":"Weiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Garibaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2014.08.018_bib1","doi-asserted-by":"crossref","first-page":"390701","DOI":"10.1155\/2012\/390701","article-title":"An exploration of apathy and impulsivity in Parkinson disease","volume":"2012","author":"Ahearn","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib2","first-page":"159","article-title":"The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia","volume":"25","author":"Alphs","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib3","first-page":"26","article-title":"The 4-item negative symptoms assessment (NSA-4) instrument: a simple tool for evaluating negative symptoms in schizophrenia following brief training","volume":"7","author":"Alphs","year":"2010","journal-title":"Psychiatry (Edgemont)"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib4","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1002\/mpr.339","article-title":"Validation of a 4-item negative symptom assessment (NSA-4): a short-practical clinical tool for the assessment of negative symptoms in schizophrenia","volume":"20","author":"Alphs","year":"2011","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/01.jcp.0000222513.63767.de","article-title":"A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia","volume":"26","author":"Alvarez","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1982.04290070020005","article-title":"Negative symptoms in schizophrenia. Definition and reliability","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0022-3956(93)90036-2","article-title":"Validation of the 16-item negative symptom assessment","volume":"27","author":"Axelrod","year":"1993","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/mds.23872","article-title":"Impact of apathy on health-related quality of life in recently diagnosed Parkinson\u05f3s disease: the ANIMO study","volume":"27","author":"Benito-Leon","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jad.2009.11.019","article-title":"Factor structure of the brief psychiatric rating scale in unipolar depression","volume":"124","author":"Biancosino","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.euroneuro.2014.08.018_bib10","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0924-977X(97)00420-3","article-title":"Development and validation of a social functioning scale, the social adaptation self-evaluation scale","volume":"7","author":"Bosc","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0010-440X(00)90133-0","article-title":"Assessment of social functioning in depression","volume":"41","author":"Bosc","year":"2000","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/schbul\/8.3.470","article-title":"Measurement of premorbid adjustment in chronic schizophrenia","volume":"8","author":"Cannon-Spoor","year":"1982","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson\u05f3s disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u05f3s disease: results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib15","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/schbul\/sbp030","article-title":"Intrinsic Motivation Inventory: an adapted measure for schizophrenia research","volume":"36","author":"Choi","year":"2009","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1176\/jnp.2007.19.1.57","article-title":"Apathy in dementia: an examination of the psychometric properties of the apathy evaluation scale.","volume":"19","author":"Clarke","year":"2007","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1176\/jnp.2008.20.3.337","article-title":"Apathy in dementia: clinical and sociodemographic correlates","volume":"20","author":"Clarke","year":"2008","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jpsychores.2010.01.012","article-title":"Are the available apathy measures reliable and valid? A review of the psychometric evidence","volume":"70","author":"Clarke","year":"2011","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.parkreldis.2009.09.004","article-title":"Olfaction and apathy in Parkinson\u05f3s disease","volume":"16","author":"Cramer","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000334314","article-title":"Clinical correlates of apathy in patients recently diagnosed with Parkinson\u05f3s disease: the ANIMO study","volume":"38","author":"Cubo","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2012.08.019","article-title":"Duration of untreated negative and positive symptoms of psychosis and cognitive impairment in first episode psychosis","volume":"141","author":"Cuesta","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib22","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"Suppl. 6","key":"10.1016\/j.euroneuro.2014.08.018_bib23","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The Neuropsychiatric Inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/089198870101400211","article-title":"Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer\u05f3s disease","volume":"14","author":"Cummings","year":"2001","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib25","author":"Cummings","year":"2009","journal-title":"Neuropsychiatric Inventory. Comprehensive assessment of psychopathology in patients with dementia"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib26","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1017\/S1041610210000876","article-title":"The neuropsychiatric inventory-clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia","volume":"22","author":"de Medeiros","year":"2010","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1755-5949.2011.00236.x","article-title":"Mindfulness-based cognitive therapy for nonremitted patients with bipolar disorder","volume":"18","author":"Deckersbach","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib28","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/j.neuropsychologia.2009.07.022","article-title":"Behavioral effects of subthalamic deep brain stimulation in Parkinson\u05f3s disease","volume":"47","author":"Denheyer","year":"2009","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib29","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.neuropsychologia.2008.05.006","article-title":"Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson\u05f3s disease have separate neural substrates","volume":"46","author":"Drapier","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib30","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.parkreldis.2010.08.015","article-title":"Validation of diagnostic criteria for apathy in Parkinson\u05f3s disease","volume":"16","author":"Drijgers","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jagp.2012.12.018","article-title":"Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET)","volume":"21","author":"Drye","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib32","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/mds.21968","article-title":"The Lille apathy rating scale: validation of a caregiver-based version","volume":"23","author":"Dujardin","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib33","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/mds.25584","article-title":"Assessing apathy in everday clinical practice","volume":"28","author":"Dujardin","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2011.12.019","article-title":"Apathy in first episode psychosis patients: a ten year longitudinal follow-up study","volume":"136","author":"Evensen","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eurpsy.2007.09.002","article-title":"Assessing apathy: the use of the apathy evaluation scale in first episode psychosis","volume":"23","author":"Faerden","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib36","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1176\/ps.2009.60.11.1495","article-title":"Apathy and functioning in first-episode psychosis","volume":"60","author":"Faerden","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000201934","article-title":"Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire","volume":"78","author":"Fava","year":"2009","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib38","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/B:QURE.0000037502.64077.4d","article-title":"The development and psychometric evaluation of the motivation and energy inventory","volume":"13","author":"Fehnel","year":"2004","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib39","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1176\/appi.neuropsych.11080195","article-title":"Toys and gadgets: construct validity of apathy in Parkinson\u05f3s disease","volume":"24","author":"Ferencz","year":"2012","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WAD.0b013e3182087dbc","article-title":"The efficacy of non-pharmacological treatment for dementia-related apathy","volume":"25","author":"Ferrero-Arias","year":"2011","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4088\/JCP.10m06708","article-title":"A randomized, double-blind, Placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer\u05f3s disease","volume":"73","author":"Frakey","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/mds.23939","article-title":"Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson\u05f3s disease","volume":"27","author":"Gallagher","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S104161020200858X","article-title":"Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer\u05f3s disease","volume":"14","author":"Gauthier","year":"2002","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib44","series-title":"Frontal Systems Behavior Scale (FrSBe): Professional Manual","author":"Grace","year":"2001"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/archgenpsychiatry.2011.129","article-title":"Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia","volume":"69","author":"Grant","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: an instrument for rating the schziophrenic deficit symdrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.schres.2011.06.030","article-title":"Development and psychometric validation of the clinical assessment interview for negative symptoms (CAINS)","volume":"132","author":"Horan","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1440-1819.2011.02315.x","article-title":"Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer\u05f3s disease","volume":"66","author":"Hsieh","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib50","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1176\/jnp.12.2.233","article-title":"Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory","volume":"12","author":"Kaufer","year":"2000","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib51","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/schbul\/sbi064","article-title":"The factorial structure of the schedule for the deficit syndrome in schizophrenia","volume":"32","author":"Kimhy","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","article-title":"The schedule for the deficit syndrome: an instrument for research in schizophrenia","volume":"30","author":"Kirkpatrick","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib54","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/schbul\/sbq059","article-title":"The brief negative symptom scale: psychometric properties","volume":"37","author":"Kirkpatrick","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib55","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1017\/S1355617711001068","article-title":"Apathy and depression: separate factors in Parkinson\u05f3s disease","volume":"17","author":"Kirsch-Darrow","year":"2011","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib56","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.pnpbp.2011.11.008","article-title":"Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic","volume":"36","author":"Kitajima","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.schres.2011.07.003","article-title":"Apathy, cognitive deficits and functional impairment in schizophrenia","volume":"133","author":"Konstantakopoulos","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s004060050050","article-title":"Reliability and validity of the premorbid adjustment scale (PAS) in a German sample of schizophrenic and schizoaffective patients","volume":"248","author":"Krauss","year":"1998","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1176\/appi.ajp.2012.12010109","article-title":"The clinical assessment interview for negative symptoms (CAINS): final development and validation","volume":"170","author":"Kring","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.eurpsy.2011.04.006","article-title":"Actigraphic daytime activity is reduced in patients with cognitive impairment and apathy","volume":"28","author":"Kuhlmei","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/gps.2309","article-title":"Effectiveness of an individualized functional training program on affective disturbances and functional skills in mild and moderate dementia \u2013 a randomized controlled trial","volume":"25","author":"Lam","year":"2012","journal-title":"Int. J. Geriat. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1037\/0022-0663.98.3.567","article-title":"Why do high school students lack motivation in the classroom? Toward an understanding of academic amotivation and the role of social support","volume":"98","author":"Legault","year":"2006","journal-title":"J. Educ. Psychol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib63","first-page":"e1","article-title":"A comparative validation of the abbreviated apathy evaluation scale (AES-10) with the neuropsychiatric inventory apathy subscale against diagnostic criteria of apathy","volume":"308","author":"Leontjevas","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib64","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/gps.2813","article-title":"Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study","volume":"27","author":"Lenze","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib65","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/ageing\/afr078","article-title":"Behavioural disorders, disability and quality of life in Parkinson\u05f3s disease","volume":"40","author":"Leroi","year":"2011","journal-title":"Age. Ageing"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib66","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/JGP.0b013e3180437db3","article-title":"Development of a short version of the apathy evaluation scale specifically adapted for demented nursing home residents","volume":"15","author":"Lueken","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2012.01.004","article-title":"Prevalence of item level negative symptoms in first episode psychosis diagnoses","volume":"135","author":"Lyne","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib68","doi-asserted-by":"crossref","first-page":"391","DOI":"10.4088\/JCP.v63n0503","article-title":"Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study","volume":"63","author":"Marangell","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib69","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the apathy evaluation scale","volume":"38","author":"Marin","year":"1991","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib70","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/mds.22307","article-title":"Atomoxetine for the treatment of executive dysfunction in Parkinson\u05f3s disease: an open-label study","volume":"24","author":"Marsh","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib71","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1212\/WNL.0b013e3181c0d416","article-title":"International study on the psychometric attributes of the non-motor symptoms scale in Parkinson\u05f3s disease","volume":"73","author":"Martinez-Martin","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib72","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/archneur.56.11.1388","article-title":"The spectrum of behavioural responses to cholinesterase inhibitor therapy in Alzheimer disease","volume":"56","author":"Mega","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib73","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pnpbp.2012.02.002","article-title":"Minocycline as adjunctive therapy for patients with unipolar psychotic depression: an open-label study","volume":"37","author":"Miyaoka","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib74","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/00048678509158847","article-title":"The premorbid adjustment scale (PAS): its use in an Australian study","volume":"19","author":"Morice","year":"1985","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib76","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/mds.23792","article-title":"Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson\u05f3s disease","volume":"26","author":"Morley","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib77","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/gps.2508","article-title":"Diagnostic criteria for apathy in clinical practice","volume":"26","author":"Mulin","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psychres.2007.10.008","article-title":"A two-factor structure for the schedule for the deficit syndrome in schizophrenia","volume":"158","author":"Nakaya","year":"2008","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib79","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.parkreldis.2011.05.009","article-title":"The impact of subthalamic stimulation on non-motor symptoms of Parkinson\u05f3s disease","volume":"17","author":"Nazzaro","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib80","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0004867412459810","article-title":"The absence of depressive symptoms is not the presence of wellness: validation of the clinical positive affect scale","volume":"46","author":"Nierenberg","year":"2012","journal-title":"Aust. NZ. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/846075","article-title":"Poor dissociation of patient-evaluated apathy and depressive symptoms","volume":"2012","author":"Njomboro","year":"2012","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00019442-200102000-00007","article-title":"The impact of behavioral symptoms on activities of daily living in patients with dementia","volume":"9","author":"Norton","year":"2001","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib83","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.JGP.0000235689.42910.0d","article-title":"Epidemiology of apathy in older adults: the cache county study","volume":"15","author":"Onyike","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib84","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib85","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/JGP.0b013e3181cabcf6","article-title":"Methylphenidate for apathy and functional status in dementia of the Alzheimer type","volume":"18","author":"Padala","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.parkreldis.2007.07.015","article-title":"Validation of the unified Parkinson\u05f3s disease rating scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson\u05f3s disease","volume":"14","author":"Pedersen","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1123\/jsep.17.1.35","article-title":"Toward a new measure of intrinsic motivation, extrinsic motivation, and amotivation in sports: the sport motivation scale (SMS)","volume":"17","author":"Pelletier","year":"1995","journal-title":"J. Sport. Exercise Psychol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(99)00161-9","article-title":"Characterizing and dating the onset of symptoms in psychotic illness: the symptom onset in schizophrenia (SOS) inventory","volume":"44","author":"Perkins","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.schres.2013.06.015","article-title":"A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: a double-blind trial","volume":"149","author":"Prikryl","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.psychres.2013.04.016","article-title":"Impaired ability to imagine future pleasant events is associated with apathy in schizophrenia","volume":"209","author":"Raffard","year":"2013","journal-title":"Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib91","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jpsychires.2012.02.010","article-title":"Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram","volume":"46","author":"Raskin","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib92","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4088\/JCP.v69n0112","article-title":"Osmotic-release oral methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial","volume":"69","author":"Ravindran","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib93","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.parkreldis.2011.08.013","article-title":"Validation of the non-motor symptoms questionnaire (NMS-Quest)","volume":"18","author":"Rios-Romenets","year":"2012","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib94","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/gps.755","article-title":"The apathy inventory: assessment of apathy and awareness in Alzheimer\u05f3s disease, Parkinson\u05f3s disease and mild cognitive impairment","volume":"17","author":"Robert","year":"2002","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpsy.2008.09.001","article-title":"Proposed diagnostic criteria for apathy in Alzheimer\u05f3s disease and other neuropsychiatric disorders","volume":"24","author":"Robert","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib96","first-page":"15","article-title":"Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials","volume":"40","author":"Robinson","year":"2007","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib97","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4088\/JCP.12m08099","article-title":"Safety and efficacy of methylphenidate for apathy in Alzheimer\u05f3s disease: a randomized, placebo-controlled trial","volume":"74","author":"Rosenberg","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib98","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJMoa1005987","article-title":"Long-acting risperidone and oral antipsychotics in unstable schizophrenia","volume":"364","author":"Rosenheck","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib99","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1037\/0022-3514.43.3.450","article-title":"Control and information in the intrapersonal sphere: an extension of cognitive evaluation theory","volume":"43","author":"Ryan","year":"1982","journal-title":"J. Pers. Soc. Psychol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib101","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.schres.2009.04.007","article-title":"The premorbid adjustment scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings","volume":"112","author":"Shapiro","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib102","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4088\/JCP.09m05133blu","article-title":"Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials","volume":"70","author":"Soares","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib103","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jnnp.2005.075929","article-title":"The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson\u05f3s disease","volume":"77","author":"Sockeel","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib104","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson\u05f3s disease","volume":"4","author":"Starkstein","year":"1992","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib105","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/01.STR.24.11.1625","article-title":"Apathy following cerebrovascular lesions","volume":"24","author":"Starkstein","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib106","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1176\/appi.ajp.158.6.872","article-title":"Syndromic validity of apathy in Alzheimer\u05f3s disease","volume":"158","author":"Starkstein","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib107","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/jnnp.2004.052795","article-title":"On the overlap between apathy and depression in dementia","volume":"76","author":"Starkstein","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib108","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/mds.24061","article-title":"Apathy in Parkinson\u05f3s disease: diagnostic and etiological dilemmas","volume":"27","author":"Starkstein","year":"2012","journal-title":"Mov. Disord"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2011.09.028","article-title":"Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms","volume":"134","author":"Stauffer","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/1073191102250339","article-title":"Factor analysis of the frontal systems behavior scale (FrSBe)","volume":"10","author":"Stout","year":"2003","journal-title":"Assessment"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib111","first-page":"176","article-title":"An informant-based assessment of apathy in Alzheimer disease","volume":"15","author":"Strauss","year":"2002","journal-title":"Neuropsychiatry Neuropsychol. Behav. Neurol."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib112","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.schres.2012.10.012","article-title":"Next-generation negative symptom assessment for clinical trials: validation of the brief negative symptom scale","volume":"142","author":"Strauss","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib113","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jpsychires.2012.04.027","article-title":"Intrinsic motivation and metacognition as predictors of learning potential in patients with remitted schizophrenia","volume":"46","author":"Tas","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib114","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/awt067","article-title":"Parkinsonian apathy responds to dopaminergic D2\/D3 stimulation with piribedil","volume":"136","author":"Thobois","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib115","first-page":"64","article-title":"Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Tran","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib116","first-page":"92","article-title":"Assessment of premorbid function in first-episode schizophrenia: modifications to the premorbid adjustment scale","volume":"27","author":"van Mastrigt","year":"2002","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib117","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/0013164492052004025","article-title":"The academic motivation scale: a measure of intrinsic, extrinsic, and amotivation in education","volume":"52","author":"Vallerand","year":"1992","journal-title":"Educ. Psychol. Meas."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib118","doi-asserted-by":"crossref","first-page":"e17846","DOI":"10.1371\/journal.pone.0017846","article-title":"Apathy, but not depression, reflects inefficient cognitive strategies in Parkinson\u05f3s disease","volume":"6","author":"Varanese","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib119","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-1781(02)00264-0","article-title":"Frontal systems behavior scale in schizophrenia: relationships with psychiatric symptomatology, cognition, and adaptive function","volume":"113","author":"Velligan","year":"2002","journal-title":"Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib120","first-page":"221","article-title":"Training and quality assurance with the brief psychiatric rating scale","volume":"3","author":"Ventura","year":"1993","journal-title":"Int. J. Methods Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-1781(00)00228-6","article-title":"Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item brief psychiatric rating scale","volume":"97","author":"Ventura","year":"2000","journal-title":"Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib122","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3233\/JAD-2012-120913","article-title":"Apathy syndrome in Alzheimer\u05f3s disease: prevalence, incidence, persistence, and risk and mortality factors","volume":"33","author":"Vialta-Franch","year":"2013","journal-title":"J. Alzheimer Disord"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib123","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1185\/030079906X148319","article-title":"The onset of effect for escitalopram and its relevance for the clinical management of depression","volume":"22","author":"Wade","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib124","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gps.2507","article-title":"Effect of donepezil on emergence of apathy in mild to moderate Alzheimer\u05f3s disease","volume":"26","author":"Waldemar","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1192\/bjp.177.1.42","article-title":"Self-report quality of life measure for people with schizophrenia: the SQLS","volume":"177","author":"Wilkinson","year":"2000","journal-title":"Br. J. Psychiatry."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib126","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00019442-200002000-00010","article-title":"The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement","volume":"8","author":"Wood","year":"2000","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib127","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.psychres.2013.07.001","article-title":"The brief psychiatric rating scale (version 4.0) factorial structure and its sensitivity in the treatment of outpatients with unipolar depression","volume":"210","author":"Zanello","year":"2013","journal-title":"Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2014.08.018_bib128","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.parkreldis.2011.11.020","article-title":"Apathy and depression in Parkinson\u05f3s disease: the Belgrade PD study report","volume":"18","author":"Ziropadja","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.euroneuro.2014.08.018_bib129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004850-200403000-00003","article-title":"The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study","volume":"19","author":"Zoccali","year":"2004","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14002570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X14002570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T13:26:35Z","timestamp":1566393995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X14002570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":128,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0924977X14002570"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.08.018","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying motivational deficits and apathy: A review of the literature","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2014.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}